OREXO
Orexo develops improved specialty pharmaceuticals and treatments for new areas of use – at a lower cost, in a shorter period of time and at a lower risk – by combining known substances with patented proprietary technologies.
OREXO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1995-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.orexo.com
Total Employee:
51+
Status:
Active
Contact:
46 1 87 80 88 00
Total Funding:
72.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins Nginx Organization Schema
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-02-23 | PharmaKodex | PharmaKodex acquired by Orexo | N/A |
| 2007-11-23 | Biolipox | Biolipox acquired by Orexo | N/A |
Investors List
Apex Venture Partners
Apex Venture Partners investment in Series B - Orexo
Crédit Lyonnais Private Equity
Crédit Lyonnais Private Equity investment in Series B - Orexo
HealthCap
HealthCap investment in Series B - Orexo
Sofinnova Investments
Sofinnova Investments investment in Series B - Orexo
Auriga Partners
Auriga Partners investment in Series B - Orexo
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-11 | Orexo appoints Fredrik Järrsten as new CFO |
| 2019-12-02 | Orexo Appoints Dennis Urbaniak as Executive Vice President Digital Health |
More informations about "Orexo" on Search Engine
Corporate Governance - Orexo
Orexo - Wikipedia
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwid…See details»
Corporate Governance - orexo.com
Orexo is a Swedish public limited liability company, with its registered o!ce in Uppsala, Sweden. The company’s shares are listed on Nasdaq (Mid Cap) Stockholm under the …See details»
Pressreleases and News - Orexo
Mar 8, 2024 Orexo is celebrating 10 years on the US Pharma market - Interview with Robert DeLuca, President of Orexo US Inc. 29 September 2023. News Release – …See details»
History - Orexo
Orexo divests its subsidiary Kibion, which also includes the product Diabact® UBT. 2016. After three years in the US, Orexo sells ZUBSOLV® for more than SEK 480 million and …See details»
Orexo - Crunchbase Company Profile & Funding
Orexo is a pharmaceutical company developing improved treatments using proprietary drug delivery technology. Uppsala, Uppsala Lan, Sweden. 51-100. Post-IPO Debt. Public. …See details»
2022-03-31-Orexo publishes 2021 Annual Report
Mar 31, 2022 Orexo publishes 2021 Annual Report. 31 March 2022 · Report · Regulatory. Uppsala, Sweden - March 31, 2022 – Orexo’s Annual Report for the 2021 has been …See details»
About Orexo – blog.orexo.com
Develops improved pharmaceuticals and digital therapies addressing unmet patient needs within the growing space of substance use disorders and mental health. The products …See details»
2021-03-23-Orexo publishes Annual Report for 2020
Mar 23, 2021 About Orexo. Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of substance use disorders …See details»
News Room - Orexo
Mar 15, 2024 Europa: USA Lena Wange. IR & Corporate Communications Director. Switchboard: +46 (0)18 780 88 00. Direct phone: +46 73 064 16 36. Email: [email protected] Plats: Uppsala, SverigeSee details»
Innovation - Orexo
Orexo is a company built on the principle of innovation, fueled by the interplay between researchers and experts with different scientific backgrounds. Today innovation remains …See details»
Orexo announces positive results from pivotal trial for its leading ...
Nov 16, 2021 News provided by. Orexo. Nov 16, 2021, 02:21 ET. Share this article. UPPSALA, Sweden, Nov. 16, 2021 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) …See details»
OrgXO.com - Your Path to Organizational Excellence
OrgXO empowers you to assess your organization from various angles, uncover hidden collaboration patterns and opportunities before, during or after a major change program …See details»
Orexo US Inc.
About Us. Orexo US Inc. is a US subsidiary that is included in our Group. The US organization main mission is to commercialize our drug Zubsolv® on the American …See details»
Orexo - Digital Therapeutics Alliance
Orexo - Digital Therapeutics Alliance. Member Company. Orexo develops improved pharmaceuticals and digital therapeutics addressing unmet needs mainly within the …See details»
Products under Development - Orexo
Project in brief. Opioid overdose is a life-threatening condition, characterized by loss of consciousness and respiratory depression. Based on the proprietary drug delivery …See details»
Orexo AB (publ.)
The focus is primarily on opioid dependence and pain but the aim is to address therapeutic areas where our competence and technologies can create value. The main market today …See details»
Orexo's OX640 development results to be presented at the 2024 …
Feb 6, 2024 Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation …See details»
Orexo US Inc
Orexo US Inc. is a subsidiary of Orexo AB (publ.) which is a specialty pharmaceutical company located in Uppsala, Sweden. The US organization’s main mission is to …See details»
Orexo publishes prospectus and applies for admission to trading …
4 days ago On March 28, 2024, Orexo AB (publ), ("Orexo" or the "Company") (STO: ORX) (OTCQX: ORXOY) successfully issued senior secured callable floating rate social bonds …See details»